167 related articles for article (PubMed ID: 25461737)
1. Plasma stromal cell-derived factor 1α/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease.
Ghasemzadeh N; Hritani AW; De Staercke C; Eapen DJ; Veledar E; Al Kassem H; Khayata M; Zafari AM; Sperling L; Hooper C; Vaccarino V; Mavromatis K; Quyyumi AA
Atherosclerosis; 2015 Jan; 238(1):113-8. PubMed ID: 25461737
[TBL] [Abstract][Full Text] [Related]
2. High levels of stromal cell-derived factor-1α predict secondary cardiac events in stable patients with a history of myocardial infarction.
Matsuoka S; Uematsu M; Nakamura T; Shimizu T; Futamata M; Obata JE; Fujioka D; Nakamura K; Yoshizaki T; Kugiyama K
J Cardiol; 2017 Jan; 69(1):320-325. PubMed ID: 27496337
[TBL] [Abstract][Full Text] [Related]
3. High levels of stromal cell-derived factor-1α predict short-term progression of renal dysfunction in patients with coronary artery disease.
Uematsu M; Nakamura T; Yoshizaki T; Watanabe Y; Deyama J; Watanabe K; Kobayashi T; Fujioka D; Saito Y; Nakamura K; Kawabata K; Obata JE; Kugiyama K
Clin Exp Nephrol; 2019 Jul; 23(7):920-927. PubMed ID: 30830550
[TBL] [Abstract][Full Text] [Related]
4. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
[TBL] [Abstract][Full Text] [Related]
5. SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease.
Hodges G; Lyngbæk S; Selmer C; Ahlehoff O; Theilade S; Sehestedt TB; Abildgaard U; Eugen-Olsen J; Galløe AM; Hansen PR; Jeppesen JL; Bang CN
Scand Cardiovasc J; 2020 Dec; 54(6):339-345. PubMed ID: 32400206
[TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events.
Eapen DJ; Manocha P; Ghasemzadeh N; Patel RS; Al Kassem H; Hammadah M; Veledar E; Le NA; Pielak T; Thorball CW; Velegraki A; Kremastinos DT; Lerakis S; Sperling L; Quyyumi AA
J Am Heart Assoc; 2014 Oct; 3(5):e001118. PubMed ID: 25341887
[TBL] [Abstract][Full Text] [Related]
7. Platelet surface expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 is associated with clinical outcomes in patients with coronary artery disease.
Rath D; Chatterjee M; Borst O; Müller K; Langer H; Mack AF; Schwab M; Winter S; Gawaz M; Geisler T
J Thromb Haemost; 2015 May; 13(5):719-28. PubMed ID: 25660395
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of stromal cell-derived factor-1 in patients with coronary artery disease: effect of clinical presentation and cardiovascular risk factors.
Stellos K; Ruf M; Sopova K; Kilias A; Rahmann A; Stamatelopoulos K; Jorbenadze R; Geisler T; Gawaz M; Bigalke B
Atherosclerosis; 2011 Dec; 219(2):913-6. PubMed ID: 22015231
[TBL] [Abstract][Full Text] [Related]
9. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
Matsumoto T; Uemura S; Takeda Y; Matsui M; Okada S; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Onoue K; Kawata H; Kawakami R; Horii M; Saito Y
Intern Med; 2013; 52(10):1019-27. PubMed ID: 23676585
[TBL] [Abstract][Full Text] [Related]
10. Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A; Hornemann T
Atherosclerosis; 2015 May; 240(1):216-21. PubMed ID: 25801014
[TBL] [Abstract][Full Text] [Related]
11. Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease.
Sjaarda J; Gerstein H; Chong M; Yusuf S; Meyre D; Anand SS; Hess S; Paré G
J Am Coll Cardiol; 2018 Jul; 72(3):300-310. PubMed ID: 30012324
[TBL] [Abstract][Full Text] [Related]
12. Stromal cell-derived factor 1 as a biomarker of heart failure and mortality risk.
Subramanian S; Liu C; Aviv A; Ho JE; Courchesne P; Muntendam P; Larson MG; Cheng S; Wang TJ; Mehta NN; Levy D
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2100-5. PubMed ID: 25060794
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Clinical, Surgical and Percutaneous Treatment to Prevent Cardiovascular Events in Patients Referred for Elective Coronary Angiography: An Observational Study.
Almeida AS; Fuchs SC; Fuchs FC; Silva AG; Lucca MB; Scopel S; Fuchs FD
Vasc Health Risk Manag; 2020; 16():285-297. PubMed ID: 32764949
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation.
Olivieri O; Martinelli N; Girelli D; Pizzolo F; Friso S; Beltrame F; Lotto V; Annarumma L; Corrocher R
J Thromb Haemost; 2010 Mar; 8(3):463-71. PubMed ID: 20002542
[TBL] [Abstract][Full Text] [Related]
15. Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study.
McCarthy CP; Ibrahim NE; Lyass A; Li Y; Gaggin HK; Simon ML; Mukai R; Gandhi P; Kelly N; Motiwala SR; van Kimmenade RRJ; Massaro JM; D'Agostino RB; Januzzi JL
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29519811
[TBL] [Abstract][Full Text] [Related]
16. Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.
Ghasemzedah N; Hayek SS; Ko YA; Eapen DJ; Patel RS; Manocha P; Al Kassem H; Khayata M; Veledar E; Kremastinos D; Thorball CW; Pielak T; Sikora S; Zafari AM; Lerakis S; Sperling L; Vaccarino V; Epstein SE; Quyyumi AA
Circ Cardiovasc Qual Outcomes; 2017 Mar; 10(3):. PubMed ID: 28280039
[TBL] [Abstract][Full Text] [Related]
17. Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study.
Martinelli N; Girelli D; Baroni M; Guarini P; Sandri M; Lunghi B; Tosi F; Branchini A; Sartori F; Woodhams B; Bernardi F; Olivieri O
J Thromb Haemost; 2016 Apr; 14(4):655-66. PubMed ID: 27061056
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
[TBL] [Abstract][Full Text] [Related]
19. Platelet surface expression of SDF-1 is associated with clinical outcomes in the patients with cardiovascular disease.
Rath D; Chatterjee M; Bongartz A; Müller K; Droppa M; Stimpfle F; Borst O; Zuern C; Vogel S; Gawaz M; Geisler T
Platelets; 2017 Jan; 28(1):34-39. PubMed ID: 27463607
[TBL] [Abstract][Full Text] [Related]
20. Serum CXCL10 and CXCL12 chemokine levels are associated with the severity of coronary artery disease and coronary artery occlusion.
Tavakolian Ferdousie V; Mohammadi M; Hassanshahi G; Khorramdelazad H; Khanamani Falahati-Pour S; Mirzaei M; Allah Tavakoli M; Kamiab Z; Ahmadi Z; Vazirinejad R; Shahrabadi E; Koniari I; Kounis NG; Esmaeili Nadimi A
Int J Cardiol; 2017 Apr; 233():23-28. PubMed ID: 28189264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
